The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
Open accessAbstract
Background TNF inhibitors have revolutionized the treatment of psoriasis vulgaris, as well as psoriatic and rheumatoid arthritis, and Crohns disease. Despite our understanding that these agents block TNF, their complex mechanism of action in disease resolution is still unclear. Objective To globally analyze the genomic effects of TNF inhibition in psoriasis patients, and compare genomic profiles of patients who responded or did not respond to treatment. Methods In a clinical trial using etanercept TNF inhibitor to treat psoriasis vulgaris (n=15), Affymetrix gene arrays were used to analyze gene profiles in lesional skin at multiple time-points during drug treatment (baseline, and weeks 1, 2, 4 and 12) compared to non-lesional skin. Patients were stratified as responders (n=11) or non-responders (n=4) based on histological disease resolution. Cluster analysis was used to define gene sets that were modulated with similar magnitude and velocity over time. Results In responders, 4 clusters of down-regulated genes and 3 clusters of up-regulated genes were identified. Genes down-modulated most rapidly reflected direct inhibition of myeloid lineage immune genes. Up-regulated genes included stable dendritic cell population genes CD1c and CD207 (Langerin). Comparison of responders and non-responders revealed rapid down-modulation of innate IL-1β and IL-8 “sepsis cascade” cytokines in both groups, but only responders down-regulated IL-17 pathway genes to baseline levels. Conclusion While both responders and non-responders to etanercept inactivated “sepsis cascade” cytokines, response to etanercept is dependent on inactivation of myeloid dendritic cell genes and inactivation of Th17 immune response. Capsule Summary Cutaneous genes regulated during psoriasis treatment by etanercept provide a global view of response in disease tissue. Only responders down-regulated IL-17 pathway genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,032
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, G. G., Langley, R. G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., Dooley, L. T., & Lebwohl, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062382 · Cited by 807
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Self-citationUnderstanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 766
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676
Self-citationGottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Self-citationCCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
Yamazaki, T., Yang, X. O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N., Kang, H. S., Ma, L., Panopoulos, A. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8391 · Cited by 551
Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442
Self-citationThe extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29
Commins, S., Steinke, J. W., & Borish, L. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.026 · Cited by 321
Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G., & Lowes, M. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32282 · Cited by 300
Self-citationPossible importance of macrophage-derived mediators in acute malaria
Clark, I. A., Virelizier, J. L., Carswell, E. A., & Wood, P. R. (1981) · Infection and Immunity · doi:10.1128/iai.32.3.1058-1066.1981 · Cited by 296
Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
Nair, R. P., Ruether, A., Stuart, P. E., Jenisch, S., Tejasvi, T., Hiremagalore, R., Schreiber, S., Kabelitz, D., Lim, H. W., Voorhees, J. J., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701255 · Cited by 282
Ortega, C., Fernández-A, S., Carrillo, J. M., Romero, P., Molina, I. J., Moreno, J. C., & Santamaría, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109046 · Cited by 269
An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis
Toichi, E., Torres, G., McCormick, T. S., Chang, T., Mascelli, M. A., Kauffman, C. L., Aria, N., Gottlieb, A. B., Everitt, D. E., Frederick, B., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4917 · Cited by 229
TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells
Chomarat, P., Dantin, C., Bennett, L., Banchereau, J., & Palucka, A. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2262 · Cited by 192
Haider, A. S., Lowes, M. A., Suárez-Fariñas, M., Zaba, L. C., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K. M., & Krueger, J. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1913 · Cited by 173
Self-citationDiluvio, L., Vollmer, S., Besgen, P., Ellwart, J. W., Chimenti, S., & Prinz, J. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7104 · Cited by 157
Prinz, J. C., Groß, B., Vollmer, S., Trommler, P., Strobel, I., Meurer, M., & Plewig, G. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240315 · Cited by 152
Partial purification of a serum factor that causes necrosis of tumors.
Green, S., Dobrjansky, A., Carswell, E. A., Kassel, R., Old, L. J., Fiore, N. C., & Schwartz, M. K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.2.381 · Cited by 147
Koczan, D., Drynda, S., Hecker, M., Drynda, A., Guthke, R., Kekow, J., & Thiesen, H. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2419 · Cited by 120
Gottlieb, A. B., Cooper, K. D., McCormick, T. S., Toichi, E., Everitt, D. E., Frederick, B., Zhu, Y., Pendley, C. E., Graham, M. A., & Mascelli, M. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182112 · Cited by 108
Basso, A. S., Cheroutre, H., & Mucida, D. (2009) · Cell Research · doi:10.1038/cr.2009.26 · Cited by 103
Potential of Tumor Necrosis Factor Inhibitors in Psoriasis and Psoriatic Arthritis
Krueger, G. G., & Callis, K. P. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.2.218 · Cited by 96
Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatment
Weinshenker, B. G., Bass, B. H., Ebers, G. C., & Rice, G. P. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)80200-2 · Cited by 78
Harshlight: a "corrective make-up" program for microarray chips
Suárez‐Fariñas, M., Pellegrino, M., Wittkowski, K. M., & Magnasco, M. O. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-294 · Cited by 70
Self-citationAn extensible application for assembling annotation for genomic data
Zhang, J., Carey, V. J., & Gentleman, R. C. (2002) · Bioinformatics · doi:10.1093/bioinformatics/19.1.155 · Cited by 58
Advances in biologic therapy for ulcerative colitis and Crohn’s disease
D’Haens, G., & Daperno, M. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0041-5 · Cited by 47
What have we learned in dermatology from the biologic therapies?
Nickoloff, B. J., & Stevens, S. R. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.059 · Cited by 44
van Meurs, J. B. J., van Lent, P. L., van de Loo, A. A. J., Holthuysen, A. E. M., Bayne, E. K., Singer, I. I., & van den Berg, W. B. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.6.350 · Cited by 32
From Classical Mouse Models of Psoriasis to a Spontaneous Xenograft Model Featuring Use of AGR Mice
Nestle, F. O., & Nickoloff, B. J. (2006) · Springer eBooks · doi:10.1007/3-540-26811-1_11 · Cited by 19
Cited by
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Self-citationThe Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 789
Guttman-Yassky, E., Bissonnette, R., Ungar, B., Suárez-Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y., Xu, H., Peng, X., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 697
Self-citationChiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Self-citationThe antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 539
Metadata
- Authors
- Zaba, L. C., Suárez-Fariñas, M., Fuentes-Duculan, J., Nograles, K. E., Guttman-Yassky, E., Cardinale, I., Lowes, M. A., & Krueger, J. G.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 124
- Issue
- 5
- Pages
- 1022-1030.e395
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2151991135
- Cited by
- 303
- References
- 35
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.